SpacePharma is pioneering the commercialisation of in-orbit microgravity applications for life-sciences, medical science and materials science.
SpacePharma designs, deploys and operates disruptive, miniaturised, remotely controlled microgravity lab and manufacturing platforms in orbit.
Lihi Efremushkin
[email protected]
https://www.space4p.com/
SpacePharma designs, deploys and operates disruptive, miniaturised, remotely controlled microgravity lab and manufacturing platforms, compatible with space stations, space shuttles and independent satellites in orbit.
SpacePharma provides customers with affordable end-to-end turnkey solutions and services, from early research to full commercial production. It serves the pharmaceutical, biopharma and healthcare industries, as well as others such as the nutrition industry and the agrochemical industry.
SpacePharma’s space-proven Lab-on-a-Chip (LoC) system is embedded into its SPAD microgravity research and MOTI microgravity manufacturing platforms, which include patented fluid handling system, temperature control, microscope and other sensors.
SpacePharma successfully deployed in orbit two fully operational satellites with an on-board lab, and successfully operated three additional missions on-board the International Space Station (ISS).
Its “Pharma meets Space” outstanding management, researchers and scientists team holds and maintains a solid, proprietary and patented intellectual property, as well as established and strong academia, industry and agencies partnerships.